Home1KRYS • BIT
add
Krystal Biotech Inc
Previous close
€162.75
Year range
€110.10 - €171.35
Market cap
5.72B USD
Avg Volume
6.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 96.04M | 36.65% |
Operating expense | 49.57M | 14.72% |
Net income | 38.33M | 146.23% |
Net profit margin | 39.91 | 80.18% |
Earnings per share | 1.29 | 38.04% |
EBITDA | 39.62M | 77.13% |
Effective tax rate | 18.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 681.99M | 21.87% |
Total assets | 1.14B | 24.05% |
Total liabilities | 97.75M | 24.10% |
Total equity | 1.04B | — |
Shares outstanding | 28.94M | — |
Price to book | 4.52 | — |
Return on assets | 8.88% | — |
Return on capital | 9.61% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 38.33M | 146.23% |
Cash from operations | 52.73M | 1,365.09% |
Cash from investing | -10.52M | 45.62% |
Cash from financing | 1.80M | -83.12% |
Net change in cash | 45.06M | 440.84% |
Free cash flow | 35.03M | 529.28% |
About
Founded
2015
Headquarters
Website
Employees
275
